Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions

References

• American Cancer Society, California Division California cancer facts and figures, 2008. (2008) . Retrieved October 30, 2009, http://www.ccrcal.org/PDF/ACS2008.pdfGoogle Scholar
• Centers for Disease Control and Prevention Screening for chronic hepatitis B among Asian/Pacific Islander populations—New York City, 2005. Morbidity Mortality Weekly Rep. (2006) 55(18):505–509Google Scholar
• Centers for Disease Control and Prevention Progress in hepatitis B prevention through universal infant vaccination—China, 1997–2006. Morbidity Mortality Weekly Rep. (2007) 56(18):441–445Google Scholar
• Chang E. T., Keegan T. H., Gomez S. L., Le G. M., Clarke C. A., So S. K., Glaser S. L. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay area, 1990 through 2004. Cancer (2007) 109(10):2100–2108Crossref, Google Scholar
• Chao S. D., Cheung C., Yue A., So S. K. Low hepatitis B knowledge among perinatal healthcare providers serving county with nation's highest rate of births to mothers chronically infected with hepatitis B. (2009) Presentation, 13th International Symposium on Viral Hepatitis and Liver DiseaseMarch 20–24(American Association for the Study of Liver Diseases, Alexandria, VA) Google Scholar
• Chao S., Lee P. V., Prapong W., Su J., So S. K. High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California [Abstract]. Hepatology (2004) 40(Suppl 1):717AGoogle Scholar
• Chen J. J., Bergin M., Zhang L., Wang Z., Zhang Y., Zhao J., Su C., Chang E. T., So S. K. S. A model HBV catch-up immunization and education project in Qinghai, China. (2008) Presentation, 42nd National Immunization ConferenceMarch 17(Centers for Disease Control and Prevention, Atlanta) Google Scholar
• China Daily Nearly 80 percent foreign companies won't hire hepatitis B carriers. (2007) June 28). Retrieved October 29, 2009, http://www.chinadaily.com.cn/bizchina/2007-06/28/content_5421170.htmGoogle Scholar
• Chinese Ministry of Health The Ministry of Health conference on planning and hepatitis B immunization, malaria prevention and control work [in Chinese]. (2008) . Retrieved August 1, 2008, http://www.gov.cn/xwfb/2008-04/21/content_950425.htmGoogle Scholar
• Cotler S. J., Dhamija M. K., Siqueira F., Bartram A. H., Luc B. J., Layden T. J., Wong S. S. Hepatitis B seroprevalence and disease characteristics in an urban Chinatown community. Clinical Gastroenterology Hepatology (2009) 7(7):776–780Crossref, Google Scholar
• Custer B., Sullivan S. D., Hazlet T. K., Iloeje U., Veenstra D. L., Kowdley K. V. Global epidemiology of hepatitis B virus. J. Clinical Gastroenterology (2004) 38(10 Suppl):S158–S168Crossref, Google Scholar
• Drummond M. F., Sculpher M. J., Torrance G. W., O'Brien B. J., Stoddart G. L.Methods for the Economic Evaluation of Health Care Programmes (2005) 3rd ed.(Oxford University Press, Oxford, UK) Google Scholar
• Edmunds W. J., Medley G. F., Nokes D. J., Hall A. J., Whittle H. C. The influence of age on the development of the hepatitis B carrier state. Proc. Biol. Sci. (1993) 253(1337):197–201Crossref, Google Scholar
• Ferrante J. M., Winston D. G., Chen P. H., de la Torre A. N. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. Family Medicine (2008) 40(5):345–351Google Scholar
• Global Fund to Fight AIDS, Tuberculosis and Malaria, The (2010) . Retrieved March 12, 2010, http://www.theglobalfund.org/en/Google Scholar
• Gold M. R., Siegel J. E., Russell L. B., Weinstein M. C.Cost-Effectiveness in Health and Medicine (1996) (Oxford University Press, Oxford, UK) Crossref, Google Scholar
• Guane R., Siu P., Lam K., Kim K. E., Warren V., Liu H., Chang M.-D. Y., et al. Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States [Abstract]. Hepatology (2004) 40(Suppl 4):716AGoogle Scholar
• Hillier F. S., Lieberman G. J.Introduction to Operations Research (2005) (McGraw-Hill, New York) Google Scholar
• Hutton D. W., So S. K., Brandeau M. L. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology (2010) 51(2):405–414Crossref, Google Scholar
• Hutton D. W., Tan D., So S. K., Brandeau M. L. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann. Internal Medicine (2007) 147(7):460–469Crossref, Google Scholar
• Institute of Medicine of the National Academies Prevention and control of viral hepatitis infections in the United States. (2009) . Consensus Study, Retrieved September 9, 2009, http://iom.edu/CMS/3793/59310.aspxGoogle Scholar
• Institute of Medicine of the National AcademiesHepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C (2010) (National Academies Press, Washington, DC) Google Scholar
• Jacobs R. J., Saab S., Meyerhoff A. S. The cost effectiveness of hepatitis immunization for US college students. J. Amer. College Health (2003) 51(6):227–236Crossref, Google Scholar
• Kahn J. G., Brandeau M. L., Dunn-Mortimer J. OR modeling and AIDS policy: From theory to practice. Interfaces (1998) 28(3):3–22Link, Google Scholar
• Kanwal F., Gralnek I. M., Martin P., Dulai G. S., Farid M., Spiegel B. M. R. Treatment alternatives for chronic hepatitis B virus infection: A cost-effectiveness analysis. Ann. Internal Medicine (2005) 142(10):821–831Crossref, Google Scholar
• Lai C. J., Nguyen T. T., Hwang J., Stewart S. L., Kwan A., McPhee S. J. Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J. Cancer Ed. (2007) 22(1):37–41Crossref, Google Scholar
• Lee H., Hontz I., Warner A., Park S. J. Hepatitis B infection among Asian American Pacific Islanders in the Rocky Mountain area. Appl. Nurs. Res. (2005) 18(1):2–6Crossref, Google Scholar
• Lin S. Y., Chang E. T., So S. K. Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of 3,163 Asians in California. Hepatology (2007) 46(4):1034–1040Crossref, Google Scholar
• Liu J., Fan D. Hepatitis B in China. Lancet (2007) 369(9573):1582–1583Crossref, Google Scholar
• Lyn T. E. China's hepatitis B carriers face gloomy future. (2008) . Reuters. Retrieved October 29, 2009, http://www.reuters.com/article/healthNews/idUST25713820080319Google Scholar
• Ma G. X., Shive S. E., Toubbeh J. I., Tan Y., Wu D. Knowledge, attitudes, and behaviors of Chinese [regarding] hepatitis B screening and vaccination. Amer. J. Health Behav. (2008) 32(2):178–187Google Scholar
• Ma G. X., Fang C. Y., Shive S. E., Toubbeh J., Tan Y., Siu P. Risk perceptions and barriers to hepatitis B screening and vaccination among Vietnamese immigrants. J. Immigrant Minority Health (2007) 9(3):213–220Crossref, Google Scholar
• Margolis H. S., Coleman P. H., Brown R. E., Mast E. E., Sheingold S. H., Arevalo J. A. Prevention of hepatitis B virus transmission by immunization: An economic analysis of current recommendations. J. Amer. Medical Assoc. (1995) 274(15):1201–1208Crossref, Google Scholar
• McQuillan G. M., Coleman P. J., Kruszon-Moran D., Moyer L. A., Lambert S. B., Margolis H. S. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Amer. J. Public Health (1999) 89(1):14–18Crossref, Google Scholar
• Muennig P.Cost-Effectiveness Analyses in Health: A Practical Approach (2008) (Jossey-Bass, San Francisco) Google Scholar
• Murray C. J., Lopez A. World Health Report 2002: Reducing risks, promoting healthy life. (2002) (World Health Organization, Geneva) Google Scholar
• Owens D. K. Interpretation of cost-effectiveness analyses. J. General Internal Medicine (1998) 13(10):716–717Crossref, Google Scholar
• People's Daily Online Chinese, U.S. agencies help hepatitis B prevention in northwest China. (2006) . Retrieved November 18, 2008, http://english.peopledaily.com.cn/200609/11/eng20060911_301654.htmlGoogle Scholar
• Pisu M., Meltzer M. I., Lyerla R. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine (2002) 21(3–4):312–321Crossref, Google Scholar
• Rajendra A., Wong J. B. Economics of chronic hepatitis B and hepatitis C. J. Hepatology (2007) 47(4):608–617Crossref, Google Scholar
• San Francisco Hep B Free Campaign HEP B FREE SF. (2009) . Retrieved September 9, 2009, http://sfhepbfree.org/aboutus/Google Scholar
• Shepherd J., Jones J., Takeda A., Davidson P., Price A. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: A systematic review and economic evaluation. Health Tech. Assess. (2006) 10(28):1–200Google Scholar
• Sun Z., Ming L., Zhu X., Lu J. Prevention and control of hepatitis B in China. J. Medical Virology (2002) 67(3):447–450Crossref, Google Scholar
• Tana M., Hoda K., Hutton D. W., Wong J., Wei Y., Liu W., Hinojales N., et al. HBV screening in Asians and Pacific Islanders: An interim cost-effectiveness analysis of a single-center San Francisco program. (2009) . Working paper, California Pacific Medical Center, Department of Gastroenterology and Hepatology, San FranciscoGoogle Scholar
• United States Census Bureau (2008) . San Francisco city, California. 2006–2008 American Community Survey 3-Year Estimates. Retrieved May 20, 2010, http://factfinder.census.gov/servlet/ACSSAFFFacts?_event=ChangeGeoContext&geo_id=16000US0667000&_geoContext=01000US|04000US06|16000US0665028&_street=&_county=san+francisco&_cityTown=san+francisco&_state=04000US06&_zip=&_lang=en&_sse=on&ActiveGeoDiv=geoSelect&_useEV=&pctxt=fph&pgsl=010&_submenuId=factsheet_1&ds_name=ACS_2007_3YR_SAFF&_ci_nbr=null&qr_name=null&reg=null:null&_keyword=&_industry=Google Scholar
• Weinbaum C. M., Mast E. E., Ward J. W. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology (2009) 49(5 Suppl):S35–S44Crossref, Google Scholar
• Weinbaum C. M., Williams I., Mast E. E., Wang S. A., Finelli L., Wasley A., Neitzel S. M., Ward J. W. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Morbidity Mortality Weekly Rep. (2008) 57(RR-08):1–20Google Scholar
• World Health Organization Disease and injury country estimates. (2004) . Retrieved October 30, 2008, http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.htmlGoogle Scholar
• World Health Organization Epidemiological fact sheet on HIV and AIDS: Core data on epidemiology and response: China. (2008a) . Retrieved November 18, 2008, http://www.who.int/globalatlas/predefinedreports/EFS2008/full/EFS2008_CN.pdfGoogle Scholar
• World Health Organization The Stop TB Strategy, case reports, treatment outcomes and estimates of TB burden. (2008b) . WHO Report 2008, annex 3. Retrieved May 20, 2010, http://www.who.int/tb/publications/global_report/2008/pdf/annex_3.pdfGoogle Scholar
• World Health Organization Hepatitis B. (2008c) . Fact sheet 204. Retrieved October 29, 2009, http://www.who.int/mediacentre/factsheets/fs204/en/Google Scholar
• World Health Organization Threshold values for intervention cost-effectiveness by region. (2009) . Retrieved November 4, 2009, http://www.who.int/choice/costs/CER_levels/en/index.htmlGoogle Scholar
• World Health Organization Regional Office for the Western Pacific Malaria morbidity and mortality, 2006. (2006) . Malaria annual data. Retrieved November 18, 2008, http://www.wpro.who.int/sites/mvp/data/malaria/2006.htmGoogle Scholar
• Wu C. A., Lin S. Y., So S. K., Chang E. T. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pacific J. Cancer Prev. (2007) 8(1):127–134Google Scholar